The vitamin D receptor: New paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 2, 2010, Pages 255-269

  Pike, J Wesley ^a   Meyer, Mark B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ChIP chip analysis; Distal enhancers; Histone H4 acetylation; RNA polymerase II; Transcription; VDR gene

Indexed keywords

CALCITRIOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; HISTONE H4; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ACETYLATION; AUTOREGULATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC REGULATION; HORMONAL REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CALCITRIOL; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HOMEOSTASIS; HUMANS; MICE; MINERALS; RANK LIGAND; RATS; RECEPTORS, CALCITRIOL; TRANSCRIPTION, GENETIC;

EID: 77953927198     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2010.02.007     Document Type: Review

References (68)

1. Haussler M.R., Whitfield G.K., Haussler C.A., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998, 13(3):325-349.
2. Sutton A.L., MacDonald P.N. Vitamin D: more than a " bone-a-fide" hormone. Mol Endocrinol 2003, 17(5):777-791.
3. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29(6):726-776.
4. 3 is mediated through multiple long-range enhancers. Mol Cell Biol 2006, 26(17):6469-6486.
5. 3. Mol Endocrinol 2006, 20(6):1231-1247.
6. 3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription. Mol Endocrinol 2006, 20(9):2215-2230.
7. 3 in intestinal cells. Mol Endocrinol 2006, 20(6):1447-1461.
8. Brumbaugh P.F., Haussler M.R. 1α,25-Dihydroxycholecalciferol receptors in intestine. I. Association of 1α,25-dihydroxycholecalciferol with intestinal mucosa chromatin. J Biol Chem 1974, 249(4):1251-1257.
9. Brumbaugh P.F., Haussler M.R. 1α,25-Dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. J Biol Chem 1974, 249(4):1258-1262.
10. McDonnell D.P., Mangelsdorf D.J., Pike J.W., et al. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987, 235(4793):1214-1217.
11. Baker A.R., McDonnell D.P., Hughes M., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 1988, 85(10):3294-3298.
12. Rochel N., Wurtz J.M., Mitschler A., et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000, 5(1):173-179.
13. 3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry 2004, 43(14):4101-4110.
14. Smith C.L., O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004, 25(1):45-71.
15. Jurutka P., Hsieh J., Nakajima S., et al. Human vitamin D receptor phosphorylation by casein kinase II at Ser-208 potentiates transcriptional activation. Proc Natl Acad Sci U S A 1996, 93(8):3519-3524.
16. 3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry 1994, 33(14):4300-4311.
17. Jurutka P., Hsieh J., MacDonald P., et al. Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells. J Biol Chem 1993, 268(9):6791-6799.
18. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell 1995, 83(6):835-839.
19. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83(6):841-850.
20. Ozono K., Liao J., Kerner S.A., et al. The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. J Biol Chem 1990, 265(35):21881-21888.
21. Carlberg C. Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 2003, 88(2):274-281.
22. 3. Proc Natl Acad Sci U S A 1992, 89(17):8097-8101.
23. Dowd D.R., Sutton A.L., Zhang C., et al. Comodulators of vitamin D receptor-mediated gene expression. Vitamin D 2005, 291-304. Elsevier/Academic Press, New York. 2nd edition. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
24. Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: perspectives from mice and man. J Bone Miner Res 2008, 23(7):974-979.
25. Bouillon R., Carmeliet G., Boonen S. Ageing and calcium metabolism. Baillieres Clin Endocrinol Metab 1997, 11(2):341-365.
26. Benn B.S., Ajibade D., Porta A., et al. Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. Endocrinology 2008, 149(6):3196-3205.
27. Jimi E., Akiyama S., Tsurukai T., et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999, 163(1):434-442.
28. Leibbrandt A., Penninger J. RANK/RANKL: regulators of immune responses and bone physiology. Ann N Y Acad Sci 2008, 1143:123-150.
29. Makishima M., Lu T.T., Xie W., et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296(5571):1313-1316.
30. Bikle D.D. Vitamin D regulated keratinocyte differentiation. J Cell Biochem 2004, 92(3):436-444.
31. Demay M., MacDonald P., Skorija K., et al. Role of the vitamin D receptor in hair follicle biology. J Steroid Biochem Mol Biol 2007, 103(3-5):344-346.
32. Adorini L. Regulation of immune responses by vitamin D receptor ligands. Vitamin D 2005, 631-648. Elsevier/Academic Press, New York. 2nd edition. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
33. Prosser D.E., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004, 29(12):664-673.
34. Zierold C., Darwish H.M., DeLuca H.F. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 1995, 270(4):1675-1678.
35. 3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology 1985, 117(5):2203-2210.
36. 3. Proc Natl Acad Sci U S A 1989, 86(12):4455-4459.
37. 3- mediated transcriptional activation. Mol Endocrinol 1991, 5(3):373-385.
38. Clemens T., Tang H., Maeda S., et al. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J Bone Miner Res 1997, 12(10):1570-1576.
39. Lian J.B., Stein G.S., Javed A., et al. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 2006, 7(1-2):1-16.
40. Stein G.S., Lian J.B., Stein J.L., et al. Combinatorial organization of the transcriptional regulatory machinery in biological control and cancer. Adv Enzyme Regul 2005, 45:136-154.
41. Ducy P., Zhang R., Geoffroy V., et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89(5):747-754.
42. Shang Y., Hu X., DiRenzo J., et al. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103(6):843-852.
43. Shang Y., Myers M., Brown M. Formation of the androgen receptor transcription complex. Mol Cell 2002, 9(3):601-610.
44. Carroll J., Meyer C., Song J., et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38(11):1289-1297.
45. Lin C., Vega V., Thomsen J., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 2007, 3(6):e87.
46. Welboren W., van Driel M., Janssen-Megens E., et al. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J 2009, 28(10):1418-1428.
47. Lefterova M., Zhang Y., Steger D., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008, 22(21):2941-2952.
48. 3 in intact animals. Endocrinology 1999, 140(5):2224-2231.
49. 3 24-hydroxylase gene. J Biol Chem 1996, 271(48):30381-30385.
50. Dwivedi P., Omdahl J., Kola I., et al. Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction. J Biol Chem 2000, 275(1):47-55.
51. 3 and cAMP or PTH. Am J Physiol 1999, 276(4 Pt 1):E793-E805.
52. 3 and parathyroid hormone. J Cell Biochem 2003, 88(2):234-237.
53. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 2005, 20(2):305-317.
54. Degenhardt T., Rybakova K., Tomaszewska A., et al. Population-level transcription cycles derive from stochastic timing of single-cell transcription. Cell 2009, 138(3):489-501.
55. 3. J Biol Chem 2010, in press. DOI:10.1074/jbc.M110.119958.
56. Esteban L., Eisman J., Gardiner E. Vitamin D receptor promoter and regulation of receptor expression. Vitamin D 2005, 193-217. Elsevier/Academic Press, New York. 2nd edition. D. Feldman, J.W. Pike, F.H. Glorieux (Eds.).
57. Santiso-Mere D., Sone T., Hilliard G.M., et al. Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems. Mol Endocrinol 1993, 7(7):833-839.
58. Zella L.A., Meyer M.B., Nerenz R.D., et al. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol Endocrinol 2010, 24(1):128-147.
59. Kong Y.Y., Feige U., Sarosi I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402(6759):304-309.
60. Kong Y.Y., Yoshida H., Sarosi I., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397(6717):315-323.
61. 3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem 2003, 89(4):771-777.
62. 3. J Cell Biochem 2008, 105(5):1289-1297.
63. Mori K., Kitazawa R., Kondo T., et al. Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. J Cell Biochem 2006, 98(6):1629-1644.
64. Fu Q., Manolagas S.C., O'Brien C.A. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 2006, 26(17):6453-6468.
65. Kim S., Yamazaki M., Shevde N.K., et al. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol 2007, 21(1):197-214.
66. Galli C., Zella L.A., Fretz J.A., et al. Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappaB ligand gene reduces bone remodeling and increases bone mass. Endocrinology 2008, 149(1):146-153.
67. Bishop K.A., Meyer M.B., Pike J.W. A novel distal enhancer mediates cytokine induction of mouse RANKL gene expression. Mol Endocrinol 2009, 23(12):2095-2110.
68. Welboren W., Stunnenberg H., Sweep F., et al. Identifying estrogen receptor target genes. Mol Oncol 2007, 1(2):138-143.